These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11155896)

  • 21. [The thymus gland of rhesus macaque in SIV vaccination/infection].
    Baroni CD; Pescarmona E; Sebastiani S; Uguccioni M
    Pathologica; 2003 Oct; 95(5):230. PubMed ID: 14988981
    [No Abstract]   [Full Text] [Related]  

  • 22. Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics.
    Parker RA; Regan MM; Reimann KA
    J Virol; 2001 Nov; 75(22):11234-8. PubMed ID: 11602764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.
    Kumar R; Orsoni S; Norman L; Verma AS; Tirado G; Giavedoni LD; Staprans S; Miller GM; Buch SJ; Kumar A
    Virology; 2006 Oct; 354(1):192-206. PubMed ID: 16876224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P.
    Zhang ZQ; Schleif WA; Casimiro DR; Handt L; Chen M; Davies ME; Liang X; Fu TM; Tang A; Wilson KA; McElhaugh M; Carella A; Tan C; Connolly B; Hill S; Klein H; Emini EA; Shiver JW
    Virology; 2004 Mar; 320(1):75-84. PubMed ID: 15003864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
    Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L
    Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 25 years of HIV research! ... and what about a vaccine?
    Appay V
    Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coinfection of macaques with simian immunodeficiency virus and simian T cell leukemia virus type I: effects on virus burdens and disease progression.
    Fultz PN; McGinn T; Davis IC; Romano JW; Li Y
    J Infect Dis; 1999 Mar; 179(3):600-11. PubMed ID: 9952366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuated retrovirus vaccines and AIDS.
    Shearer GM; Lucey DR; Clerici M
    Science; 1995 Nov; 270(5239):1219; author reply 1220-2. PubMed ID: 7502053
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
    Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
    J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV vaccines: prospects and challenges.
    Baltimore D; Heilman C
    Sci Am; 1998 Jul; 279(1):98-103. PubMed ID: 9648305
    [No Abstract]   [Full Text] [Related]  

  • 33. Relevance of studying T cell responses in SIV-infected rhesus macaques.
    Valentine LE; Watkins DI
    Trends Microbiol; 2008 Dec; 16(12):605-11. PubMed ID: 18964016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconsidering an attenuated vaccine for AIDS.
    Beale J
    Lancet; 1996 Feb; 347(8998):344-5. PubMed ID: 8598696
    [No Abstract]   [Full Text] [Related]  

  • 35. AIDS and mucosal immunity: usefulness of the SIV macaque model of genital mucosal transmission.
    Miller C; Gardner MB
    J Acquir Immune Defic Syndr (1988); 1991; 4(12):1169-72. PubMed ID: 1941523
    [No Abstract]   [Full Text] [Related]  

  • 36. Changing paradigms for an HIV vaccine.
    Schultz AM
    Adv Exp Med Biol; 1996; 397():79-90. PubMed ID: 8718586
    [No Abstract]   [Full Text] [Related]  

  • 37. "The Duesberg phenomenon": what does it mean?
    Van Rompay K; Marthas ML
    Science; 1995 Jan; 267(5195):157. PubMed ID: 7809614
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings of the 23rd Annual Symposium on Nonhuman Primate Models for AIDS. September 21-24, 2005. Portland, Oregon, USA.
    J Med Primatol; 2006 Aug; 35(4-5):177-320. PubMed ID: 16872280
    [No Abstract]   [Full Text] [Related]  

  • 39. Reexamining AIDS research priorities.
    Paul WE
    Science; 1995 Feb; 267(5198):633-6. PubMed ID: 7839138
    [No Abstract]   [Full Text] [Related]  

  • 40. AIDS. Passive primate protection.
    Moore JP; Weiss RA
    Nature; 1991 Aug; 352(6334):376-7. PubMed ID: 1861715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.